Dhuwit awis saben siji saham Synlogic (SYBX)

Synlogic, Inc. (SYBX) focuses on the monetization of synthetic biology and asset restructuring. Fluctuations in cash per share, with GURU.Markets data illustrated on this chart, demonstrate capital liquidity, while 1.32 captures the current state of the parameter. Experts in "living" medicines drive development, while the environmental profile is limited to basic bio-waste disposal and green offices.
Rincian analitis perusahaan Synlogic, Inc.

Long-term capital requires strict liquidity control to minimize bankruptcy risks. For Synlogic, Inc. (SYBX), which creates programmable bacteria, maintaining reserves is critical due to the high cost of bioengineering development. Data on highly liquid assets per share is determined by dividing the cash balance by the number of securities. This metric reflects the business's real margin of safety per share. An increase in this indicator confirms the financial autonomy of this synthetic biology innovator.